INPP5D and amyloidosis: By not crossing Inpp5d−/− mice with any models of amyloidosis, we were able to investigate the effect of Inpp5d haploinsufficiency on the brain transcriptome in the absence of pathology—in other words, modeling the effects prior to disease onset.